In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pronova BioPharma ASA

Division of BASF SE
www.pronova.com

Latest From Pronova BioPharma ASA

NorthSea Raises Cash For NASH Program

NorthSea raises €25m to push icosabutate, its only clinical compound, which was licensed from Pronova BioPharma, into Phase IIb trials for fatty liver disease. The drug has previously been tested in hypertriglyceridemia and dyslipidemia.

Business Strategies Financing

Omega-3 Petition Seeks Unqualified Blood Pressure, CHD Claims

The trade group Global Organization for EPA and DHA Omega-3 petitions FDA for an unqualified health claim related to reduced blood pressure as a surrogate marker for coronary heart disease risk.

Consumer Regulation

Omega-3 Petition Seeks Unqualified Blood Pressure, CHD Claims

The trade group Global Organization for EPA and DHA Omega-3 petitions FDA for an unqualified health claim related to reduced blood pressure as a surrogate marker for coronary heart disease risk.

Consumer Regulation

New Cholesterol Guidelines Follow Long History Of Failed Outcomes Trials

The cardiology community is increasingly questioning the value of adding on a variety of lipid therapies to treatment with highly effective statins, based on accumulating evidence of the lack of value of affecting cholesterol parameters other than LDL.

Clinical Trials Research and Development Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Nutraceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Pronova Biocare AS
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Norway
  • Parent & Subsidiaries
  • BASF SE
  • Senior Management
  • Morten Jurs, CEO
    Synne H Roine, CFO
    Hilde Steineger, VP, Bus. Dev.
  • Contact Info
  • Pronova BioPharma ASA
    Phone: (47) 2253 4850
    Vollsveien 6
    P.O. Box 420 Lysaker, NO-1327
    Norway
Advertisement
Advertisement
UsernamePublicRestriction

Register